223 related articles for article (PubMed ID: 33750234)
1. Circulating tumour DNA methylation in hepatocellular carcinoma diagnosis using digital droplet PCR.
Wang J; Yang L; Diao Y; Liu J; Li J; Li R; Zheng L; Zhang K; Ma Y; Hao X
J Int Med Res; 2021 Mar; 49(3):300060521992962. PubMed ID: 33750234
[TBL] [Abstract][Full Text] [Related]
2. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
[TBL] [Abstract][Full Text] [Related]
3. A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma.
Kim SC; Kim DW; Cho EJ; Lee JY; Kim J; Kwon C; Kim-Ha J; Hong SK; Choi Y; Yi NJ; Lee KW; Suh KS; Kim W; Kim W; Kim H; Kim YJ; Yoon JH; Yu SJ; Kim YJ
Mol Cancer; 2023 Oct; 22(1):164. PubMed ID: 37803338
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
[TBL] [Abstract][Full Text] [Related]
5. Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma.
Luo B; Ma F; Liu H; Hu J; Rao L; Liu C; Jiang Y; Kuangzeng S; Lin X; Wang C; Lei Y; Si Z; Chen G; Zhou N; Liang C; Jiang F; Liu F; Dai W; Liu W; Gao Y; Li Z; Li X; Zhou G; Li B; Zhang Z; Nian W; Luo L; Liu X
BMC Med; 2022 Jan; 20(1):8. PubMed ID: 35027051
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma.
Xu RH; Wei W; Krawczyk M; Wang W; Luo H; Flagg K; Yi S; Shi W; Quan Q; Li K; Zheng L; Zhang H; Caughey BA; Zhao Q; Hou J; Zhang R; Xu Y; Cai H; Li G; Hou R; Zhong Z; Lin D; Fu X; Zhu J; Duan Y; Yu M; Ying B; Zhang W; Wang J; Zhang E; Zhang C; Li O; Guo R; Carter H; Zhu JK; Hao X; Zhang K
Nat Mater; 2017 Nov; 16(11):1155-1161. PubMed ID: 29035356
[TBL] [Abstract][Full Text] [Related]
7. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.
Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ
Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma.
Yan L; Chen Y; Zhou J; Zhao H; Zhang H; Wang G
Int J Infect Dis; 2018 Feb; 67():92-97. PubMed ID: 29229500
[TBL] [Abstract][Full Text] [Related]
9. Early detection of hepatocellular carcinoma via no end-repair enzymatic methylation sequencing of cell-free DNA and pre-trained neural network.
Deng Z; Ji Y; Han B; Tan Z; Ren Y; Gao J; Chen N; Ma C; Zhang Y; Yao Y; Lu H; Huang H; Xu M; Chen L; Zheng L; Gu J; Xiong D; Zhao J; Gu J; Chen Z; Wang K
Genome Med; 2023 Nov; 15(1):93. PubMed ID: 37936230
[TBL] [Abstract][Full Text] [Related]
10. Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Hu N; Fan XP; Fan YC; Chen LY; Qiao CY; Han LY; Wang K
Tohoku J Exp Med; 2017 Jun; 242(2):93-100. PubMed ID: 28592717
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma detection via targeted enzymatic methyl sequencing of plasma cell-free DNA.
Guo P; Zheng H; Li Y; Li Y; Xiao Y; Zheng J; Zhu X; Xu H; He Z; Zhang Q; Chen J; Qiu M; Jiang M; Liu P; Chen H
Clin Epigenetics; 2023 Jan; 15(1):2. PubMed ID: 36600275
[TBL] [Abstract][Full Text] [Related]
12. Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta-analysis.
Zhang Z; Chen P; Xie H; Cao P
Cancer Med; 2020 Feb; 9(4):1349-1364. PubMed ID: 31876977
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.
Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R
Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301
[TBL] [Abstract][Full Text] [Related]
14. Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for Cancer Patients.
Choy LYL; Peng W; Jiang P; Cheng SH; Yu SCY; Shang H; Olivia Tse OY; Wong J; Wong VWS; Wong GLH; Lam WKJ; Chan SL; Chiu RWK; Chan KCA; Lo YMD
Clin Chem; 2022 Sep; 68(9):1151-1163. PubMed ID: 35587130
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsies.
Gonçalves E; Gonçalves-Reis M; Pereira-Leal JB; Cardoso J
Sci Rep; 2022 Jul; 12(1):11512. PubMed ID: 35798798
[TBL] [Abstract][Full Text] [Related]
16. Circulating Cell-Free DNA and DNA Integrity as Molecular Diagnostic Tools in Hepatocellular Carcinoma.
Elzehery R; Effat N; El Farahaty R; Elsayed Farag R; Abo-Hashem EM; Elhelaly R
Am J Clin Pathol; 2022 Aug; 158(2):254-262. PubMed ID: 35403666
[TBL] [Abstract][Full Text] [Related]
17. Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma.
Marchio A; Amougou Atsama M; Béré A; Komas NP; Noah Noah D; Atangana PJA; Camengo-Police SM; Njouom R; Bekondi C; Pineau P
Clin Exp Med; 2018 Aug; 18(3):421-431. PubMed ID: 29749584
[TBL] [Abstract][Full Text] [Related]
18. Plasma SGIP1 methylation in diagnosis and prognosis prediction in hepatocellular carcinoma.
Xie GF; Xu YX; Xu F; Sun LY; Ye ZL; Ma JJ; Wang HY; Shao JY
Neoplasma; 2021 Jan; 68(1):62-70. PubMed ID: 33118832
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection.
Wang P; Song Q; Ren J; Zhang W; Wang Y; Zhou L; Wang D; Chen K; Jiang L; Zhang B; Chen W; Qu C; Zhao H; Jiao Y
Sci Transl Med; 2022 Nov; 14(672):eabp8704. PubMed ID: 36417488
[TBL] [Abstract][Full Text] [Related]
20. Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients.
Wang D; O'Rourke D; Sanchez-Garcia JF; Cai T; Scheuenpflug J; Feng Z
BMC Cancer; 2021 Jul; 21(1):797. PubMed ID: 34243735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
